Michael was asked to go and meet Sarcoma UK to hear about their work supporting people affected by sarcoma cancer. Michael welcomed Sarcoma UK’s latest report, The Loneliest Cancer, which provides a frank look at the current provision for sarcoma care in the UK.
The report reveals how sarcoma and a general lack of awareness of the cancer can have a devastating impact on people. Initial diagnosis is often inaccurate and compared to other more common cancers, fewer treatment options are available. This means that currently only 55% of sarcoma patients live beyond five years.
Michael said
"I’m proud to work with sarcoma to help spread awareness of this terrible cancer. It’s also clear to see that more needs to be done to help understand sarcoma so that patients have access to the level of treatment and care they deserve."
Richard Davidson, CEO of Sarcoma UK, said:
‘Being little recognised and far from fully understood has led to a range of issues which seem unique to sarcoma cancer. By working alongside policymakers, the NHS and healthcare professionals, Sarcoma UK is committed to ensuring sarcomas are diagnosed sooner, more effective and kinder treatment options are made available and access to new drugs is improved, so that together, we can improve the lives of everyone affected by sarcoma.’
Sarcoma can affect any part of the body, inside or out, including the muscle, bone, tendons, blood vessels and fatty tissues. In the UK, 5,300 people are diagnosed every year, that’s 15 people every day.
Sarcoma UK is a national charity that funds vital research, offers support for anyone affected by sarcoma cancer and campaigns for better treatments.
